SYNERGY has obtained the European Pharmacopoeia Adaptation CertificateZhitong·Sep 16, 2025 at 03:57 AM300636+0.60%
SYNERGY: CMO/CDMO business is expected to achieve rapid growth in 2027 and 2028Zhitong·Sep 1, 2025 at 12:38 AM300636+0.60%
SYNERGY: The raw material drug Amlodipine Besylate has passed the GMP compliance inspectionZhitong·Aug 14, 2025 at 03:22 AM300636+0.60%
SYNERGY: Agomelatine and Opicapone have obtained drug registration certificates in South KoreaZhitong·Jul 22, 2025 at 04:45 AM300636+0.60%
Zhitong A-shares lock-up release overview | June 27Zhitong·Jun 26, 2025 at 08:01 PM600458+0.18%688206+3.82%
SYNERGY: Tofisopam has obtained the drug registration certificate in South KoreaZhitong·May 27, 2025 at 02:58 AM300636+0.60%
01:00 ET ALLPACK INDONESIA 2025: Featuring Innovations in Packaging, Plastics, Processing, Printing, Recycling & Pharmaceuticals, Strengthening Indonesia- Italy Synergy in Innovation and Sustainabilityprnewswire·May 27, 2025 at 12:00 AMPKG-1.37%300636+0.60%
SYNERGY released its first-quarter performance, with a net profit attributable to the parent company of 20.7814 million yuan, a decrease of 52.30%Zhitong·Apr 24, 2025 at 07:09 AM300636+0.60%
SYNERGY: Plans to increase its investment in Hangzhou Boya by 11 million yuan, raising its shareholding ratio to 24.9285%Zhitong·Apr 24, 2025 at 05:26 AM300636+0.60%
SYNERGY: Obtained the Korean Drug Registration CertificateZhitong·Apr 15, 2025 at 03:38 AM300636+0.60%
===== SYNERGY: Empagliflozin has received a drug registration certificate in South Korea =====Zhitong·Feb 19, 2025 at 03:53 AM300636+0.60%
SYNERGY: Mirabegron has obtained the drug registration certificate in South KoreaZhitong·Feb 17, 2025 at 04:35 AM300636+0.60%
